New contact lens aims to correct nearsightedness safely

NCT ID NCT06716372

Completed Symptom relief Sponsor: Visco Vision Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a new daily disposable contact lens called DSiHy for correcting nearsightedness (myopia). 134 adults who already wore contacts were randomly assigned to use either the new lens or a standard daily lens. The goal was to see if the new lens provides clear vision (20/20 or better) and is safe to wear.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DSiHy Silicone Hydrogel Soft Contact Lens
What this could lead to: If successful, this could offer a new daily disposable contact lens option for people with nearsightedness, providing clear vision with good safety.
What could go wrong: This is a completed trial comparing two similar contact lenses, so major breakthroughs are unlikely. The main risk is typical contact lens discomfort or eye irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA REFRACTIVE ERRORS

Contacts and locations

Locations

Chang Gung Memorial Hospital, Linkou

Taoyuan, Taiwan
Chang Gung Memorial Hospital, Taipei

Taipei, Taiwan
Tri-Service General Hospital

Taipei, 114202, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.